Bellicum Pharmaceuticals

About:

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).

Website: http://www.bellicum.com

Twitter/X: BellicumPharma

Top Investors: Hercules Capital, RA Capital Management, Perceptive Advisors, Redmile Group, Cancer Prevention and Research Institute of Texas

Description:

Bellicum Pharmaceuticals is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response.